Zimmermann Martine 4
4 · LIGAND PHARMACEUTICALS INC · Filed Jun 10, 2025
Insider Transaction Report
Form 4
Zimmermann Martine
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-06+5,783→ 5,783 totalExercise: $105.99Exp: 2035-06-06→ Common Stock (5,783 underlying) - Award
Common Stock
2025-06-06+1,209→ 4,746 total - Tax Payment
Common Stock
2025-06-06$105.99/sh−188$19,926→ 4,558 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
- [F3]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.